Skip to content

Effect of Açaí Juçara Consumption on Endothelial Function and Arterial Stiffness

Effect of Açaí Juçara Consumption on Endothelial Function and Arterial Stiffness in Overwheight or Obese Individuals: A Randomized Clinical Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04434534
Enrollment
60
Registered
2020-06-17
Start date
2018-06-01
Completion date
2020-12-28
Last updated
2020-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight and Obesity

Keywords

Endhothelial function, Anthocyanins, Arterial stiffness, Açaí Juçara

Brief summary

This study evaluates the consumption of Açaí Juçara pulp in endothelial function and arterial stiffness in overwheight and obese individuals. Half of participants will receive a hipocaloric diet and two Açaí Juçara pulps for daily consumption, while the other half will receive just a hipocaloric diet.

Detailed description

Obesity is the most prevalent nutritional disease and a growing public health problem worldwide. This clinical condition is an established risk factor for cardiovascular diseases. Açaí Juçara is a brazilian fruit, rich in antioxidants, like anthocyanin. This compound have antioxidative and vasodilatory properties. Prospective studies have shown that the antioxidant present in berries can improve vascular health, like endothelial function, measured by Flow Mediated Dilatation (FMD) and arterial stiffness, measured by Pulse Wave Velocity (PWV).

Interventions

DIETARY_SUPPLEMENTHipocaloric Diet with Açaí Juçara

Daily consumption of Açaí Juçara pulp (200g) and nutritional adequacy of meals in individualized diet plans calculated for each participant.

OTHERHipocaloric Diet

Nutritional adequacy of meals in individualized diet plans calculated for each participant.

Sponsors

Instituto de Cardiologia do Rio Grande do Sul
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
30 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Sedentary lifestyle * Overwheight or obesity 1 diagnostic (BMI \>25kg/m² and \<35kg/m²)

Exclusion criteria

* Alcoolism * Smoking * Diagnostic of Diabetes Mellitus or Coronary Artery Disease * Use of Statin Therapy * Cardiovascular diseases * Infectious Disease

Design outcomes

Primary

MeasureTime frameDescription
Flow-mediated Dilation (FMD)12 weeksThe non-invasive evaluation of endothelial function in the brachial artery will be performed at the Laboratory of Clinical Investigation of the Institute of Cardiology of Rio Grande do Sul. The images will be captured by a trained professional in the method using ultrasonography equipament with a linear transducer. The acquisition of the image will be through the program Ulead Video Studio (EasyCap). The protocol consist in 1 minute of baseline recording of the arterial flow diameter, followed by 5 minutes of reactive hyperemia (cuff occlusion in the forearm) and then 3 minutes recording after cuff deflation. The exams will be record in a video, and later analyzed through the Cardiovascular Suite software. The FMD will be evaluated before the beginning of the diet and after 12 weeks of diet.

Secondary

MeasureTime frameDescription
Pulse Wave Velocity12 weeksThe calibrated and validated Mobil-O-Graph® portable monitor will be used. This module is connected to a computer to record the brachial pulse wave. It performs pulse wave analysis based on the oscillometric method. The arterial pulsation generates pressure oscillations, which are transmitted to the blood pressure cuff and measured by the transducer to be interpreted by a specific software, recording the pulse wave of the brachial artery and deriving a pulse wave from the aortic arch. All measurements will be performed by the same evaluator on the right side of the volunteer. Participants will be instructed to be in 12 hours os fasting. The pulse wave velocity will be evaluated before the beginning of the diet and after 12 weeks of diet.

Countries

Brazil

Contacts

Primary ContactTainah Ortiz
tainahortiz05@gmail.com55 51 999171990
Backup ContactAlexandre Lehnen, PhD
amlehnen@gmail.com55 51 999768092

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026